CS
Candriam SCA Portfolio holdings
AUM
$17.3B
This Quarter Return
+7.7%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$5.72B
AUM Growth
+$5.72B
(+7.6%)
Cap. Flow
+$150M
Cap. Flow
% of AUM
2.62%
Top 10 Holdings %
Top 10 Hldgs %
15.98%
Holding
775
New
66
Increased
306
Reduced
280
Closed
46
Top Buys
| 1 |
Microsoft
MSFT
|
$45.2M |
| 2 |
Procter & Gamble
PG
|
$30.3M |
| 3 |
Baidu
BIDU
|
$29.9M |
| 4 |
Bristol-Myers Squibb
BMY
|
$24.2M |
| 5 |
Eli Lilly
LLY
|
$23M |
Top Sells
| 1 |
GE Aerospace
GE
|
$29.4M |
| 2 |
SPLS
Staples Inc
SPLS
|
$26.4M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$25.3M |
| 4 |
Motorola Solutions
MSI
|
$24.5M |
| 5 |
Amgen
AMGN
|
$23.9M |
Sector Composition
| 1 | Healthcare | 27.14% |
| 2 | Technology | 13.78% |
| 3 | Financials | 13.55% |
| 4 | Consumer Discretionary | 9.45% |
| 5 | Communication Services | 7.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Microsoft
MSFT
$3.77T
| $121M | 2.12% | 1,628,790 +607,240 | +59% | +$45.2M |
|
|
CELG
2
DELISTED
Celgene Corp
CELG
| $118M | 2.06% | 809,688 -19,598 | -2% | -$2.86M |
|
3
Apple
AAPL
$3.45T
| $104M | 1.82% | 676,798 -86,424 | -11% | -$13.3M |
|
4
Gilead Sciences
GILD
$140B
| $92.1M | 1.61% | 1,136,201 -289,860 | -20% | -$23.5M |
|
5
Biogen
BIIB
$19.4B
| $88.4M | 1.55% | 282,477 +62,876 | +29% | +$19.7M |
|
|
6
Amgen
AMGN
$155B
| $86.4M | 1.51% | 463,575 -128,168 | -22% | -$23.9M |
|
7
Exxon Mobil
XOM
$487B
| $82.6M | 1.44% | 1,007,290 +4,370 | +0.4% | +$358K |
|
8
Alibaba
BABA
$322B
| $79M | 1.38% | 457,449 +53,031 | +13% | +$9.16M |
|
9
Amazon
AMZN
$2.44T
| $73.1M | 1.28% | 76,062 -8,450 | -10% | -$8.12M |
|
10
Johnson & Johnson
JNJ
$427B
| $69.5M | 1.21% | 534,689 +26,071 | +5% | +$3.39M |
|
11
Meta Platforms (Facebook)
META
$1.86T
| $66.4M | 1.16% | 388,611 -8,619 | -2% | -$1.47M |
|
|
12
Alphabet (Google) Class A
GOOGL
$2.57T
| $61.4M | 1.07% | 63,073 -26,011 | -29% | -$25.3M |
|
13
Regeneron Pharmaceuticals
REGN
$61.5B
| $58.6M | 1.02% | 130,992 +3,449 | +3% | +$1.54M |
|
14
Vertex Pharmaceuticals
VRTX
$100B
| $54.6M | 0.95% | 358,862 +85,442 | +31% | +$13M |
|
|
15
Procter & Gamble
PG
$368B
| $51.2M | 0.89% | 563,001 +332,722 | +144% | +$30.3M |
|
16
Microchip Technology
MCHP
$35.1B
| $48.3M | 0.84% | 537,463 +2,446 | +0.5% | +$220K |
|
17
JPMorgan Chase
JPM
$829B
| $47.7M | 0.83% | 499,336 -57,874 | -10% | -$5.53M |
|
18
Incyte
INCY
$16.5B
| $46.1M | 0.81% | 394,758 +38,014 | +11% | +$4.44M |
|
19
AT&T
T
$209B
| $45.5M | 0.8% | 1,162,127 -1,414 | -0.1% | -$55.4K |
|
20
Verizon
VZ
$186B
| $39.9M | 0.7% | 805,414 -13,772 | -2% | -$682K |
|
|
21
Bristol-Myers Squibb
BMY
$96B
| $39.7M | 0.69% | 623,191 +379,592 | +156% | +$24.2M |
|
22
Citigroup
C
$178B
| $38.9M | 0.68% | 535,279 +36,461 | +7% | +$2.65M |
|
23
UnitedHealth
UNH
$281B
| $38.5M | 0.67% | 196,780 -4,392 | -2% | -$860K |
|
24
Merck
MRK
$210B
| $38M | 0.66% | 592,695 -14,215 | -2% | -$910K |
|
|
ALXN
25
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $37.7M | 0.66% | 268,918 +46,820 | +21% | +$6.57M |
|